Metastatic Castration-resistant Prostatic Neoplasms trials recruiting in District of Columbia

Fewer than 3 recruiting trials found.

All Metastatic Castration-resistant Prostatic Neoplasms trials nationally

Cities in District of Columbia

Recruiting trials in District of Columbia

• A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
  NCT07164443 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · District of Columbia: Washington D.C.